We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Upgraded Optical Component Enhances Automated Living Cell Research System

By LabMedica International staff writers
Posted on 21 Dec 2010
Print article
An upgraded automatic imaging system equipped with state-of-the-art optics is now available for studying living cells under flow conditions.

The Fluxion Biosciences Inc. (San Francisco, CA, USA) BioFlux 1000 system has enabled a wide variety of cell-based assays in the fields of immunology, vascular biology, microbiology, cancer research, stem cells, and more. Many of these applications, such as platelet adhesion, cell adhesion, rolling velocity, transmigration, and stem cell differentiation, have benefited from the system's ability to create a physiologically relevant shear-flow profile. Other applications, such as wound healing, chemotaxis, pharmacology, and neurite-outgrowth assays, benefited from its ability to introduce compounds and gradients in a time-resolved and well-controlled manner.

The BioFlux system utilizes a unique microfluidic design to enable automated cellular analyses in the presence of controlled shear flow. Micron-scale flow channel devices are integrated into standard microtiter plates. The lower surface of these devices is formed by cover slip glass optimized for high resolution microscopy data.

The new BioFlux 1000Z instrument maintains the BioFlux 1000's integrated system for automated, high-throughput shear-flow assays. This includes the BioFlux controller and a integrated imaging workstation, including a state of the art inverted microscope, automated XY stage, automated fluorescence, auto focus module, CCD camera, and PC workstation. In the new BioFlux 1000Z system, the optical component is based on the Zeiss (Jena, Germany) AxioObserver microscope. New modules for this platform include Zeiss' proprietary Definite Focus LED-based autofocus mechanism and PlasDIC module for differential internal contrast imaging.

"We are pleased to launch this new addition to the BioFlux product family,” said Michael Schwartz, program director at Fluxion Biosciences. "Carl Zeiss has a worldwide reputation for advanced optics and superb engineering. The combination of Zeiss microscopy hardware with Fluxion's Well Plate Microfluidic technology provides an advanced solution for cellular research and drug discovery.”

Related Links:
Fluxion Biosciences Inc.
Zeiss

New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Adenovirus Detection Kit
REALQUALITY RQ-ADENO
New
Urine Collection Container
Urine Monovette

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.